N-[2-[(4-Methyl-2-oxo-2H-1-benzopyran-7-yl)oxy]acetyl]-S-(phenylmethyl)-D-cysteine
97%
- Product Code: 215174
CAS:
1573150-21-6
| Molecular Weight: | 427.4702 g./mol | Molecular Formula: | C₂₂H₂₁NO₆S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | 734.8±60.0 °C(Predicted) | |
| Density: | 1.347±0.06 g/cm3(Predicted) | Storage Condition: | 2-8°C |
Product Description:
Used as an intermediate in the synthesis of anticoagulant drugs, particularly in the development of coumarin-based derivatives that modulate blood clotting. Its structure supports the design of compounds with enhanced metabolic stability and targeted inhibition of vitamin K epoxide reductase. Commonly employed in pharmaceutical research to optimize antithrombotic agents with improved pharmacokinetic profiles.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 10mg | 10-20 days | $413.25 |
+
-
|
| 25mg | 10-20 days | $635.78 |
+
-
|
| 100mg | 10-20 days | $1,907.33 |
+
-
|
N-[2-[(4-Methyl-2-oxo-2H-1-benzopyran-7-yl)oxy]acetyl]-S-(phenylmethyl)-D-cysteine
Used as an intermediate in the synthesis of anticoagulant drugs, particularly in the development of coumarin-based derivatives that modulate blood clotting. Its structure supports the design of compounds with enhanced metabolic stability and targeted inhibition of vitamin K epoxide reductase. Commonly employed in pharmaceutical research to optimize antithrombotic agents with improved pharmacokinetic profiles.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :